Patents by Inventor Ifat SHER-ROSENTHAL

Ifat SHER-ROSENTHAL has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD AND SYSTEM FOR IMAGING EYE BLOOD VESSELS
    Publication number: 20230360220
    Abstract: A method of diagnosing a condition of a subject, comprises: receiving image data of an anterior of an eye of the subject, and analyzing the image data to detect at least one of: flow of individual blood cells in libmal or conjunctival blood vessels of the eye, morphology of limbal or conjunctival blood vessels. The method also comprises determining the condition of the subject based on the detection(s).
    Type: Application
    Filed: July 18, 2023
    Publication date: November 9, 2023
    Applicants: Ramot at Tel-Aviv University Ltd., Tel HaShomer Medical Research Infrastructure and Services Ltd.
    Inventors: Ygal ROTENSTREICH, Ifat SHER ROSENTHAL, Haim SUCHOWSKI, Michael MREJEN, Shahar KATZ
  • TREATMENT OF RETINAL DISORDERS
    Publication number: 20230355727
    Abstract: Ophthalmic formulations comprising a PAR1 antagonist and/or an agent that interferes with an interaction of PAR1 and a protease (e.g., thrombin), and an ophthalmically acceptable carrier, and uses thereof in treating or preventing retinal pathologies such as retinal degeneration, are provided. The agent can be, for example, a peptide conjugate represented by Formula I, as defined in the specification.
    Type: Application
    Filed: May 9, 2023
    Publication date: November 9, 2023
    Applicant: Tel HaShomer Medical Research Infrastructure and Services Ltd.
    Inventors: Joab CHAPMAN, Efrat SHAVIT STEIN, Ygal ROTENSTREICH, Ifat SHER ROSENTHAL
  • ENHANCING EPITHELIAL INTEGRITY BY A SEQUENCE OF MAGNETIC PULSES
    Publication number: 20220023654
    Abstract: The invention provides a method of noninvasively treating a condition associated with reduced integrity or increased permeability of an epithelial layer by a series of magnetic pulses having a magnitude of up to 3 T, wherein the magnetic pulses are designed to induce an electric field having a magnitude of up to 250 Volt per meter adjacent to a target treatment area, the condition particularly being ocular condition associated with reduced barrier function of the cornea. The invention provides a device for effecting the tissue treatment, creating series of pulses exhibiting a rate of change of more than 200 T/s in the absolute value.
    Type: Application
    Filed: August 9, 2021
    Publication date: January 27, 2022
    Applicant: EPITECH MAG LTD.
    Inventors: Tomer CARMELI, Ifat SHER-ROSENTHAL, Ygal ROTENSTREICH, Itzik RONEN
  • Enhancing epithelial integrity by a sequence of magnetic pulses
    Patent number: 11083908
    Abstract: The invention provides a method of noninvasively treating a condition associated with reduced integrity or increased permeability of an epithelial layer by a series of magnetic pulses having a magnitude of up to 3 T, wherein the magnetic pulses are designed to induce an electric field having a magnitude of up to 250 Volt per meter adjacent to a target treatment area, the condition particularly being ocular condition associated with reduced barrier function of the cornea. The invention provides a device for effecting the tissue treatment, creating series of pulses exhibiting a rate of change of more than 200 T/s in the absolute value.
    Type: Grant
    Filed: July 19, 2018
    Date of Patent: August 10, 2021
    Assignee: EPITECH MAG LTD.
    Inventors: Tomer Carmeli, Ifat Sher-Rosenthal, Ygal Rotenstreich, Itzik Ronen
  • ENHANCING EPITHELIAL INTEGRITY BY A SEQUENCE OF MAGNETIC PULSES
    Publication number: 20190046810
    Abstract: The invention provides a method of noninvasively treating a condition associated with reduced integrity or increased permeability of an epithelial layer by a series of magnetic pulses having a magnitude of up to 3 T, wherein the magnetic pulses are designed to induce an electric field having a magnitude of up to 250 Volt per meter adjacent to a target treatment area, the condition particularly being ocular condition associated with reduced barrier function of the cornea. The invention provides a device for effecting the tissue treatment, creating series of pulses exhibiting a rate of change of more than 200 T/s in the absolute value.
    Type: Application
    Filed: July 19, 2018
    Publication date: February 14, 2019
    Inventors: Tomer CARMELI, Ifat SHER-ROSENTHAL, Ygal ROTENSTREICH, Itzik RONEN
  • Device and method for reducing the permeability of the cornea
    Patent number: 10058710
    Abstract: The present invention provides a device and a method for non-invasively enhancing the integrity of the cornea by applying a magnetic field, thereby treating eye disorders.
    Type: Grant
    Filed: May 4, 2014
    Date of Patent: August 28, 2018
    Assignee: Tel Hashomer Medical Research Infrastructure and Services Ltd.
    Inventors: Ifat Sher-Rosenthal, Ygal Rotenstreich
  • DEVICE AND METHOD FOR REDUCING THE PERMEABILITY OF THE CORNEA
    Publication number: 20160106996
    Abstract: The present invention provides a device and a method for non-invasively enhancing the integrity of the cornea by applying magnetic field, whereby treating eye disorders.
    Type: Application
    Filed: May 4, 2014
    Publication date: April 21, 2016
    Inventors: Ifat SHER-ROSENTHAL, Ygal ROTENSTREICH